| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881014 | The Annals of Thoracic Surgery | 2007 | 6 Pages |
Abstract
The mortality and morbidity in redo valve surgery with aprotinin administration was comparable with primary valve surgery without aprotinin. Bleeding and transfusion requirements were significantly lower in redo patients receiving aprotinin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alfredo J. MD, PhD, Paulo Roberto B. MD, PhD, Solange MD, Paula M. MD, Lafaiete MD, Adilson S. MD, Walter Villela MD, PhD,